Medicine and Allergy/Intolerance Data Transfer
Information Standard Notice
Acting under delegated authority from the Secretary of State for Health, the Data Coordination Board has approved a change to an existing information standard for publication under section 250 of the Health and Social Care Act 2012.
Important: Full conformance date
You must comply with this change by the full conformance date: 31 March 2023
Standard definition
- Unique identifier
DAPB4013 Amd 5/2021
- Name
- Medicine and Allergy/Intolerance Data Transfer
- Publication version
- 1.0.0
- Approval date
- 30 September 2021
- Publication date
- 30 September 2021
- Documentation
- opens in a new tab
(opens in new tab)
Standard definition
- Description
- Sets out definitions to be used when a health professional sends or receives patient medication and allergy/intolerance information by computer system between care locations.
About this change
- Scope
- Health Services, NHS Services
- Applies to
- All NHS care locations that:
- need to know a patient’s current medicines and allergies/intolerance
- prescribe, dispense or administer medicines
- use computer systems that could send or receive this information
- This includes acute, ambulance, community, mental health, specialist trusts, GP practices and community pharmacies
- Impacts upon
- Implementation of this information standard impacts all health IT systems suppliers providing systems to the above providers; suppliers should work with their customers to determine necessary changes.
- Link to further information
- Further information
Contacts
- Sponsor
Fintan Grant, Programme Head – Interoperable Medicines, NHS Digital
- SRO
- Ann Slee, Associate Chief Clinical Information Officer (Medicines), NHSX
- Business Lead
- Andrew Walsham, Senior Project Manager - Interoperable Medicine Standards, NHS Digital
- Help Desk
Dates
- Implementation Date
- 1 October 2021
- Full Conformance Date
- 31 March 2023
- Post Implementation Review date
- 31 March 2024